Paul advises biopharmaceutical and medical device clients on growth strategies, new product strategy, franchise strategic marketing, and pricing and reimbursement. He also serves as co-Chair of Putnam’s Talent Committee.
During his consulting career, Paul has assisted pharmaceutical and biotechnology companies in business development, R&D strategy, product valuations, product launch planning, market assessments, forecasting and global pricing & reimbursement strategy. Paul joined the firm from the Life Sciences practice at L.E.K. Prior to entering consulting, Paul performed R&D management roles in two early stage medical technology companies. He co-founded a medical imaging company that was subsequently acquired by an international pharmaceutical corporation. In addition, Paul worked as a Research Manager at Amersham Health (now GE Healthcare). He is an author of 25 scientific publications and 8 patents. Paul holds a Ph.D. in Physics from Princeton University, an MBA from Columbia Business School, and a BA in Physics and History from Swarthmore College.